Table 2. Composite and simple outcomes – univariate analyses.

ACEI – angiotensin-converting enzyme inhibitors; ARB – angiotensin II receptor blockers; CI – confidence interval; NS – not significant; OR – odds ratio

	30-day mortality/ventilation			30-day mortality			30-day ventilation
Variables	OR	CI 95%	p	OR	CI 95%	p	OR	CI 95%	p
Age	1.04	1.02-1.06	<0.001	1.08	1.05-1.12	<0.001	0.97	0.95-0.99	0.006
Sex (male)	1.06	1.02-1.06	NS	1.11	0.66-1.88	NS	1.14	0.59-2-21	NS
Medical History
Arterial hypertension	1.48	0.85-2.60	NS	2.00	1.10-3.77	0.027	0.89	0.45-1.84	NS
Chronic pulmonary disease	1.41	0.72-2.78	NS	0.73	0.34-1.48	NS	2.22	1.00-4.74	0.042
Obesity	0.51	0.25-0.99	0.052	0.54	0.25-1.10	NS	0.66	0.24-1.56	NS
Active cancer	2.69	1.15-6.85	0.027	3.15	1.36-7.57	0.008	1.16	0.37-3.07	NS
Chronic kidney disease	0.91	0.48-1.73	NS	1.48	0.77-2.83	NS	0.26	0.06-0.76	0.031
Diabetes mellitus	0.98	0.60-1.68	NS	1.05	0.60-1.84	NS	0.88	0.42-1.76	NS
Chronic heart disease	1.00	0.59-1.69	NS	1.57	0.91-2.71	NS	0.41	0.18-0.88	0.028
Immunosuppression	0.45	0.06-2.13	NS	0.30	0.02-1.80	NS	0.76	0.04-4.58	NS
Dyslipidemia	0.55	0.33-0.91	0.021	0.60	0.35-1.02	0.061	0.85	0.43-1.63	NS
Atrial fibrillation	1.11	0.57-2.19	NS	1.39	0.69-2.74	NS	0.59	0.19-1.48	NS
Chronic medication
ACEI/ARB	0.82	0.49-1.36	NS	0.85	0.50-1.45	NS	0.84	0.43-1.63	NS
Statin	0.92	0.55-1.52	NS	0.73	0.43-1.25	NS	1.00	0.51-1.92	NS
Antiplatelet	1.21	0.68-2.14	NS	1.38	0.76-2.48	NS	0.58	0.24-1.26	NS
Anticoagulants	0.86	0.42-1.72	NS	1.15	0.55-2.35	NS	0.36	0.08-1.07	NS
Symptoms for >7 days	0.73	0.40-1.32	NS	0.30	0.13-0.60	0.001	2.70	1.34-5.39	0.005
Drugs during hospitalization
Hydroxychloroquine	0.71	0.43-1.17	NS	0.34	0.20-0.59	<0.001	3.36	1.67-7.13	0.001
Lopinavir/ritonavir	0.60	0.31-1.14	NS	0.78	0.39-1-50	NS	0.72	0.28-1-64	NS